Why Audit Observations Often Repeat in Pharma Manufacturing
Every pharma manufacturing leader has faced this moment: an audit closes; observations are addressed, CAPAs are documented—and yet, during the next inspection, similar findings resurface. Different wording, same root issues.
This is not a failure of intent or effort. It is a structural problem in how most pharma organizations approach compliance, execution, and learning from audits.
Repeated audit observations are a symptom, not a disease.
The Illusion of “Closed” Observations
On paper, audit observations are closed efficiently:
- Root cause analysis is completed
- Corrective and preventive actions are documented
- Training records are updated
- Evidence is archived
From a compliance standpoint, everything appears complete.
But in practice, most CAPAs focus on documentation correction, not execution correction. The underlying behaviors, decision paths, and operational dependencies remain unchanged.
As a result, the same risks quietly rebuild themselves between audits.
Root Cause Analysis Often Stops Too Early
In many cases, investigations identify causes such as:
- “Operator not adequately trained”
- “Procedure not followed”
- “Documentation error”
These conclusions are convenient—but shallow.
They rarely ask deeper questions:
- Why did the operator rely on memory instead of the SOP?
- Why was deviation detection delayed?
- Why did supervision not catch the issue in real time?
- Why did the system allow an incorrect step to proceed?
When root causes are framed as human failure rather than system failure, solutions default to retraining instead of redesign.
SOPs Exist, But They Don’t Guide Execution
Most pharma plants have robust SOP libraries. The problem is not availability—it’s usability.
SOPs are:
- Static documents in dynamic environments
- Written for audits, not execution
- Detached from real-time decision-making
On the shop floor, operators work under time pressure, equipment variability, and production targets. Expecting perfect recall of procedures in these conditions is unrealistic.
When SOPs don’t actively guide execution, informal practices fill the gap—and those practices are rarely audit-proof.
Compliance Is Still Largely Reactive
Traditional compliance models operate in a loop:
- Execute process
- Record data
- Review after completion
- Investigate deviations
- Fix documentation
This means issues are detected after they’ve already occurred.
Get Larisa Albanians’s stories in your inbox
Join Medium for free to get updates from this writer.
Repeated observations happen because organizations respond to audit findings rather than preventing their recurrence now of execution. By the time auditors return, the same vulnerabilities have already been re-emerged.
Knowledge Silos Amplify the Problem
Another reason observations repeat is inconsistent knowledge transfer.
Critical process understanding often lives with:
- A few experienced operators
- Specific shifts or teams
- Individual supervisors
When these individuals change roles, shifts, or leave, undocumented know-how disappears. New staff follow procedures mechanically, without understanding the “why,” increasing the likelihood of errors that mirror past findings.
Auditors don’t see intent—they see outcomes. And outcomes repeat when institutional knowledge is fragmented.
CAPAs Focus on Proof, Not Prevention
Many CAPAs are designed to satisfy auditors, not to change operations.
They prioritize:
- Additional signatures
- Extra forms
- More checks at the end of the process
What’s missing is real-time enforcement—mechanisms that prevent incorrect steps from happening in the first place.
Without this shift, organizations accumulate compliance layers without actually reducing risk.
Why Digital Systems Alone Don’t Solve It
Even plants with MES, QMS, and LMS platforms still face repeated observations.
Why?
Because most systems:
- Capture data but don’t interpret context
- Enforce workflows but not decisions
- Record deviations but don’t guide prevention
Technology that digitizes existing processes without changing how work is executed simply accelerates documentation—not compliance with maturity.
The Strategic Shift Needed to Break the Cycle
To stop repeating audit observations, pharma manufacturers must move from evidence-based compliance to execution-based compliance.
This means:
- Embedding guidance into workflows, not documents
- Detecting risk during execution, not after batch completion
- Supporting operators now decisions are made
- Designing systems that reduce dependency on memory and interpretation
Auditors reward control, consistency, and predictability. These outcomes cannot be trained into existence—they must be designed into operations.
Final Perspective
Repeated audit observations are not signs of poor-quality teams or weak intent. They are signals that compliance is still being treated as a reporting function rather than an operational capability.
Until compliance is enforced where work happens—on the shop floor, in real time—audits will continue to surface familiar findings.
The goal is not to survive audits better.
The goal is to make audits uneventful.
